AstraZeneca's patent cliff

Mar 21, 2013 : Like many pharmaceutical companies AstraZeneca is facing a patent cliff. Lex's Stuart Kirk and Oliver Ralph discuss how new chief executive Pascal Soriot is tackling the slide in revenue.
1 - 12 COMPANIES & MANAGEMENT (30)